Clinical Trial

ORI-Guided Oxygen Therapy During One-Lung Ventilation

Study acronym: ORI-OLV
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
High inspired oxygen concentrations (FiO₂) are commonly administered during general anesthesia to prevent hypoxemia. However, excessive oxygen administration may result in hyperoxemia, which has been associated with impaired hypoxic pulmonary vasoconstriction, increased oxidative stress, ventilation-perfusion mismatch, and postoperative pulmonary complications. During one-lung ventilation (OLV) for thoracic surgery, higher FiO₂ is often required because of increased intrapulmonary shunting, making hyperoxemia a frequent occurrence. The Oxygen Reserve Index (ORI) is a noninvasive pulse oximetry-derived parameter that reflects moderate hyperoxemia (PaO₂ approximately 100-200 mmHg) and may facilitate more precise oxygen titration than pulse oximetry alone.
Trial Details
NCT Number NCT07720778
Lead Sponsor Konkuk University Medical Center
Conditions Thoracic Surgery With One-lung Ventilation
Enrollment 58 participants
Start Date 2026-08-01
Primary Completion 2028-04-30 (estimated)
Study Completion 2028-04-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-22